# System Assessment

## Current placement

ICARUS/AEGIS currently fits the **advanced independent quantitative R&D / pre-institutional platform** band.

It is substantially beyond a normal retail indicator or single-script automation stack because it already contains research governance, deterministic replay/provenance controls, activation quarantine, paper/live separation, risk-state controls, and test infrastructure.

It is not yet equivalent to a mature institutional production platform because execution reconciliation, venue-native futures connectivity, point-in-time data breadth, distributed/HPC experimentation, market-microstructure realism, portfolio-level risk, and independent production evidence remain incomplete.

## Maturity ladder

1. Retail indicator/algo stack — chart logic, basic backtests, discretionary tuning.
2. Serious systematic retail — Python research, costs, automation, basic out-of-sample testing.
3. Advanced independent quant R&D — reproducibility, holdouts, research ledgers, stress tests, deterministic replay, execution safeguards.
4. Professional quant platform / small institutional desk — point-in-time data, portfolio construction, multiple-testing controls, production execution/reconciliation, monitoring, disaster recovery, forward validation.
5. Elite electronic/quant infrastructure — massive proprietary datasets, specialized teams, exchange-level microstructure, distributed compute, low-latency execution, large-scale experimentation, continuous production feedback.

**Current ICARUS position:** Level 3 overall, with selected research-governance and reproducibility components beginning to touch Level 4.

## Strongest existing foundations

- Disjoint research partitions and untouched holdout discipline.
- Persistent holdout-consumption/selection controls.
- Cost stress and qualification concepts.
- Frozen replay and source/config/data fingerprinting.
- TradingView/parity validation.
- Separation of research output from execution authorization.
- Paper/live identity boundaries.
- Activation quarantine and controlled promotion.
- Pause/flatten execution controls.
- Authentic trade-event aggregation without inventing quote-book information.
- Cross-platform test intent (Linux + Windows workflows).

## Highest-value gaps

### Statistical validity
Add persistent experiment-attempt accounting, family-level multiple-testing control, Deflated Sharpe Ratio, Probability of Backtest Overfitting / CSCV, bootstrap uncertainty, negative controls, parameter-neighborhood stability, and regime holdout matrices.

### Data truth
Move from "provider adapters" toward a point-in-time truth fabric carrying event time, publication time, receipt time, revision lineage, source identity, entitlement state, freshness, and conflict state.

### Execution
Build a futures-native execution state machine with intent IDs, broker IDs, idempotency, partial fills, cancel/replace races, reconnect recovery, rejection taxonomy, and authoritative position reconciliation.

### Microstructure
Keep existing trade-footprint analytics separate from genuine L1/L2 quote-event analytics. Do not treat aggressor-volume proxies as order-flow imbalance.

### Portfolio risk
Add contract-value normalization, gross/net exposure, correlated risk clusters, vol targeting, session/event budgets, rolling loss constraints, global kill/flatten gates, and broker-vs-engine reconciliation.

### Operations
Make observability tamper-evident and independently auditable; improve CI reliability; add fault injection, restart/recovery tests, and deterministic incident replay.

## What should *not* be done

- Do not simply add more indicators or exotic transforms to the voting stack.
- Do not call realized volatility "implied volatility" or a volatility-risk-premium substitute.
- Do not infer queue position without data that can support queue-state reconstruction.
- Do not use report dates for macro/COT research when the information became public later.
- Do not optimize on the final holdout repeatedly.
- Do not claim institutional-grade, alpha, or capacity without forward evidence.
